Navigation Links
AMN Healthcare Announces First Quarter 2009 Results
Date:5/7/2009

As of March 31, 2009 2008 Leverage Ratio (6) 1.3 1.5

  1. Adjusted EBITDA represents net income (loss) plus interest expense (net of interest income), income taxes, depreciation and amortization, restructuring charges, impairment charges, non-recurring legal expenses and stock-based compensation expense. Management presents adjusted EBITDA because it believes that adjusted EBITDA is a useful supplement to net income as an indicator of operating performance. Management believes that adjusted EBITDA is an industry-wide financial measure that is useful both to management and investors when evaluating the company's performance. Management also uses adjusted EBITDA for planning purposes. Management uses adjusted EBITDA to evaluate the company's performance because it believes that adjusted EBITDA more accurately reflects the company's results, as it excludes certain items, in particular stock-based compensation charges that management believes are not indicative of the company's operating performance. However, adjusted EBITDA is not intended to represent cash flows for the period, nor has it been presented as an alternative to operating or net income as an indicator of operating performance, and it should not be considered in isolation or as a substitute for measures of performance prepared in accordance with GAAP. As defined, adjusted EBITDA is not necessarily comparable to other similarly titled captions of other companies due to potential inconsistencies in the method of calculation. While management believes that some of the items excluded from adjusted EBITDA are not indicative of the company's operating performance, these items do impact the income statement, and management therefore utilizes adjusted EBITDA as an operating performance measure in conjunction with GAAP me
    '/>"/>

SOURCE AMN Healthcare Services, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine news :

1. Quest Diagnostics to Speak at the Bank of America and Merrill Lynch 2009 Healthcare Conference
2. HMS Holdings Corp. to Present at Bank of America and Merrill Lynch 2009 Healthcare Conference
3. MedPage Today(R) Named Best Online Healthcare Publication
4. ViroPharma to Present at Two May Healthcare Conferences
5. Decho Doubles Number of Mozy Healthcare Customers
6. NuVasive to Present at Bank of America and Merrill Lynch 2009 Healthcare Conference
7. Physicians Choice Leverages InstaMeds Integrated Platform for Healthcare Payment & Clearinghouse Solutions
8. Symmetry Medical to Present at Bank of America and Merrill Lynch 2009 Healthcare Conference
9. AMN Healthcare Services to Present at the Bank of America and Merrill Lynch 2009 Health Care Conference and at the Robert W. Baird 2009 Growth Stock Conference
10. South Africa not Gaining the Full Benefit of PPPs in the Healthcare Sector, Says Frost & Sullivan
11. Ohio Selects APS Healthcare to Manage Unified Population Health Management Program for State Employees
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/17/2014)... A Diet Doc in-house clinical study ... are turning back the clock on aging, looking younger ... the company has recently added their prescription anti-aging human ... prescription and non-prescription diet products and healthy living supplements. ... best anti-aging human growth hormone therapy to their ...
(Date:11/17/2014)... Oskaloosa, IA (PRWEB) November 17, 2014 ... featured in an upcoming episode of American Farmer airing ... Tuesday at 8:30 am ET on RFD-TV. , World ... organic plant based proteins. World Food’s unique system provides ... seed to protein ingredients. , This segment will educate ...
(Date:11/17/2014)... (PRWEB) November 17, 2014 QuickChek customers ... their September “Dog Tag” Promotion. In total, ... Hope For The Warriors® in support of military families ... is a national nonprofit dedicated to restoring a sense ... for our service members and our military families. ...
(Date:11/17/2014)... (PRWEB) November 17, 2014 For the ... specialist used DNA sequencing from a single cell extracted ... that ran in the father’s family. Double-board certified expert ... Springs and Newport Beach, then implanted only the healthy ... , “The world of In Vitro Fertilization has taken ...
(Date:11/17/2014)... (PRWEB) November 17, 2014 Wright & ... Miami ordered Boston Scientific Corp. to pay a total ... who filed bladder mesh lawsuits after they suffered injuries ... company’s Pinnacle transvaginal mesh implant. Bloomberg reported that jurors ... defectively designed and the company failed to warn physicians ...
Breaking Medicine News(10 mins):Health News:Best Anti-Aging Human Growth Hormone Therapy Safely and Naturally Restores Diet Doc Patients to More Youthful Levels 2Health News:Best Anti-Aging Human Growth Hormone Therapy Safely and Naturally Restores Diet Doc Patients to More Youthful Levels 3Health News:American Farmer to Feature World Food Processing in 2015 Series 2Health News:QuickChek Gives Big Support to Hope For The Warriors One Dollar at a Time 2Health News:IVF Specialist From American Reproductive Centers Performs World's First DNA Sequencing On Single Cell So Defected Genes Won't Be Passed To Future Generations 2Health News:Boston Scientific Ordered To Pay $28.7 Million In Bladder Mesh Lawsuits After Injuries From Pelvic Mesh Implant Reports Wright & Schulte LLC 2Health News:Boston Scientific Ordered To Pay $28.7 Million In Bladder Mesh Lawsuits After Injuries From Pelvic Mesh Implant Reports Wright & Schulte LLC 3Health News:Boston Scientific Ordered To Pay $28.7 Million In Bladder Mesh Lawsuits After Injuries From Pelvic Mesh Implant Reports Wright & Schulte LLC 4
... a History of Eating Disorders More at Risk for ... for Eating and Anxiety Disorders ( www.remudaranch.com ), the ... new pressure to look perfect while pregnant. "With the ... an increased pressure to look perfect and thin during ...
... is the only authorized online learning program ... Known for bringing innovation to the chiropractic ... only web-based seminar program dedicated exclusively to ... Online, the online learning system authorized by ...
... 19 Abbott announced today,that the U.S. ... the Clinical Laboratory Improvement Amendments of 1988 (CLIA) for ... analyzer. , Cartridges for E3+, ... patient,s,metabolic state within a few minutes. The glucose ...
... Amazing Heat Pack by Comfort Now, Inc., a revolutionary ... pain relief for athletes, arthritics, chronic pain sufferers, premenstrual ... musclesBURLINGTON, Ontario, Jan. 19 Not since the 1920 ... aid product been released as The Amazing Heat Pack, ...
... Commitment to Healthy and Successful Vascular Access for ... Vascular Access(SM), the nation,s leading provider of vascular ... of managed vascular access centers has collectively ,touched, ... Lifeline Vascular Access managed center Nephrology Vascular Lab ...
... The 2008 Frost & Sullivan Technology Innovation Award ... presented to TECNIMED srl for pioneering THERMOFOCUS, the first ... available with a new, rapid, room temperature stabilization system. ... the company that has demonstrated technological superiority within its ...
Cached Medicine News:Health News:Remuda Ranch Reports More Women Seek to Be Thin During Pregnancy 2Health News:Activator Methods Introduces Web-Based Seminar Program 2Health News:Abbott Receives FDA CLIA Waiver for Use of Five Additional Cartridges on the i-STAT Handheld Blood Analyzer 2Health News:Abbott Receives FDA CLIA Waiver for Use of Five Additional Cartridges on the i-STAT Handheld Blood Analyzer 3Health News:The Amazing Heat Pack: The Most Innovative First Aid Solution Since the Band-Aid 2Health News:Lifeline Vascular Access Treats a Quarter Million Patients 2Health News:Lifeline Vascular Access Treats a Quarter Million Patients 3Health News:TECNIMED Picks Up Frost & Sullivan Award for its Innovative THERMOFOCUS 2Health News:TECNIMED Picks Up Frost & Sullivan Award for its Innovative THERMOFOCUS 3Health News:TECNIMED Picks Up Frost & Sullivan Award for its Innovative THERMOFOCUS 4
(Date:11/17/2014)... PARK, Calif. , Nov. 17, 2014 ... company in the emerging field of regenerative medicine, today ... President of Research and Development, will participate in a ... for Regenerative Medicine (CIRM) discussing the latest progress in ... The CIRM Google Hangout session is scheduled for ...
(Date:11/17/2014)... Wilson Therapeutics AB, a development stage biopharmaceutical company, ... study to evaluate efficacy and safety of its lead ... disorder and designated orphan disease, in which the body ... delighted to proceed with this important clinical study in ... development program for WTX101," said David Clark , ...
(Date:11/17/2014)... 2014  Inovio Pharmaceuticals, Inc. (NASDAQ: INO ... their 2013 collaboration, option, and license agreement to co-develop ... as their research collaboration in prostate cancer. All of ... the product to other parties, will be returned to ... phase I clinical trial in the first half of ...
Breaking Medicine Technology:Asterias Biotherapeutics to Participate in Live Google Hangout Discussion of Stem Cell-Based Therapies for Spinal Cord Injury 2Wilson Therapeutics Announces Start Of Phase 2 Study To Evaluate The Efficacy And Safety Of WTX101 In Newly Diagnosed Wilson Disease Patients 2Wilson Therapeutics Announces Start Of Phase 2 Study To Evaluate The Efficacy And Safety Of WTX101 In Newly Diagnosed Wilson Disease Patients 3Inovio Pharmaceuticals to Independently Develop Prostate Cancer Immunotherapy; Will Maintain Collaboration and License Agreement with Roche for Inovio's Hepatitis B Immunotherapy 2Inovio Pharmaceuticals to Independently Develop Prostate Cancer Immunotherapy; Will Maintain Collaboration and License Agreement with Roche for Inovio's Hepatitis B Immunotherapy 3Inovio Pharmaceuticals to Independently Develop Prostate Cancer Immunotherapy; Will Maintain Collaboration and License Agreement with Roche for Inovio's Hepatitis B Immunotherapy 4Inovio Pharmaceuticals to Independently Develop Prostate Cancer Immunotherapy; Will Maintain Collaboration and License Agreement with Roche for Inovio's Hepatitis B Immunotherapy 5
... NEW YORK, June 2, 2011 Citeline, the world,s ... recently completed a comprehensive review of clinical trial starts ... patterns in drug development. Over the one-year review period ... trials were initiated in the oncology sector, more than ...
... Syndax Pharmaceuticals, a clinical-stage epigenetics oncology company, today ... Trademark Office of Patent Application Serial No. 12/549458 ... This follows the UK issuance which was granted ... patent estate. The patent covers the ...
Cached Medicine Technology:Investment in Oncology Drug Development Remains Strong as 133 Companies Initiate Late-Stage Clinical Trials Representing a 21% Increase 2Investment in Oncology Drug Development Remains Strong as 133 Companies Initiate Late-Stage Clinical Trials Representing a 21% Increase 3Syndax Pharmaceuticals Announces Issuance of US Patent for Entinostat 2Syndax Pharmaceuticals Announces Issuance of US Patent for Entinostat 3
... The Vitros 250 is ... meet requirements in multiple environments ... large hospitals, clinics and satellite ... features on-board dilution, and can ...
The IMx system is an automated analyzer designed to perform microparticle enzyme immunoassay (MEIA), fluorescence polarization immunoassay (FPIA) and ion capture technologies....
Architect i2000 is a flexible solution for your evolving laboratory providing high throughput and walkaway time with built-in flexibility....
... The Bayer Immuno 1 provides ... immunoassay instrument with over 50 ... endocrinology, tumor marker, therapeutic drug, ... can be performed on a ...
Medicine Products: